e-learning
resources
Milan 2017
Monday, 11.09.2017
Efficacy of and compliance with obstructive sleep apnoea treatment
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Effects of CPAP treatment on anxiety and depression in patients with OSAS
N. Fouz Rosón (Barcelona, Spain)
Source:
International Congress 2017 – Efficacy of and compliance with obstructive sleep apnoea treatment
Session:
Efficacy of and compliance with obstructive sleep apnoea treatment
Session type:
Thematic Poster
Number:
2273
Disease area:
Sleep and breathing disorders
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Fouz Rosón (Barcelona, Spain). Effects of CPAP treatment on anxiety and depression in patients with OSAS. 2273
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
Effect of CPAP adherence on depression in OSA patient
Source: Virtual Congress 2020 – Treatment of obstructive sleep apnoea and its effects
Year: 2020
The effects of anxiety and depression on treatment adherence in COPD patients
Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities
Year: 2010
Acute psychosis after CPAP treatment in a schizophrenic patient with sleep apnoea{-}hypopnoea syndrome
Source: Eur Respir J 2001; 17: 313-315
Year: 2001
Insomnia, OSAS and CPAP treatment
Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy
Year: 2008
Effects of CPAP treatment in UARS patients comparing to OSAS patients
Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea
Year: 2007
Effect of nCPAP-therapy to depressive symptoms in patients with obstructive sleep apnea
Source: Annual Congress 2010 - Sleep disorders: neurology, smoking and daytime sleepiness
Year: 2010
Evaluation quality of life, anxiety, and depression in patients with obstructive sleep syndrome before and after three and twelve months of continuous positive airway pressure therapy
Source: Virtual Congress 2021 – Advances in therapeutic plans for sleep disordered breathing
Year: 2021
The effect of CPAP in asthma patients with SAHS
Source: Virtual Congress 2021 – Home mechanical ventilation: organisation and outcomes
Year: 2021
Patients initial experiences of sleep apnea CPAP treatment
Source: International Congress 2018 – Contemporary respiratory care: symptoms, the role of the nurse and the organisation of care
Year: 2018
Impact of pulmonary rehabilitation on anxiety and depression in patients with COPD
Source: Annual Congress 2008 - Impact of rehabilitation programmes in COPD and non-COPD patients
Year: 2008
Effects of a lifestyle intervention in obese obstructive sleep apnoea patients treated with CPAP
Source: Annual Congress 2012 - Sleep apnoea: clinical topics
Year: 2012
Effects of CPAP treatment on 6MWD in OSAS and overlap syndrome patients
Source: Eur Respir J 2002; 20: Suppl. 38, 294s
Year: 2002
Do beta-blockers reduce sympathetic activity in patients with mild sleep breathing disorder without CPAP therapy?
Source: Virtual Congress 2020 – Treatment of obstructive sleep apnoea and its effects
Year: 2020
Nocturnal BP pattern and cardiovascular risk in a group of patients with moderate-severe OSAS. Evaluation of the effect of CPAP treatment
Source: Eur Respir J 2007; 30: Suppl. 51, 335s
Year: 2007
Biofeedback for panic disorder in patients with COPD
Source: Annual Congress 2008 - Organisation of care and management of COPD
Year: 2008
Does persistent daytime hypersomnolence in CPAP treated patients with OSAS reflect comorbid narcolepsy or restless legs syndrome ?
Source: Annual Congress 2010 - Sleep disorders: neurology, smoking and daytime sleepiness
Year: 2010
Why excessive sleepiness may persist in OSA patients receiving adequate CPAP treatment
Source: Eur Respir J 2011; 39: 227-228
Year: 2012
Why excessive sleepiness may persist in OSA patients receiving adequate CPAP treatment
Source: Eur Respir J 2011; 39: 226-227
Year: 2012
Why excessive sleepiness may persist in OSA patients receiving adequate CPAP treatment
Source: Eur Respir J 2012; 39: 226-227
Year: 2012
Why excessive sleepiness may persist in OSA patients receiving adequate CPAP treatment
Source: Eur Respir J 2012; 39: 227-228
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept